Pharma

Network with leading clinical data disclosure, transparency and plain language summaries community.

Our speakers represent today’s leading scientists working across all stages of biopharmaceutical development and production. By attending, you’ll hear 90+ speakers present novel case studies, new data and critical industry trends designed to accelerate your biologics towards commercial success.The BPI US West scientific agenda covers today’s latest innovations across all phases of biopharmaceutical development and manufacturing. Your registration provides access to all 6 conference tracks as well two weeks of on demand access to all of the conference recordings post-event.

The BPI Europe 2022 scientific agenda covers today’s latest innovations across all phases of biopharmaceutical development and manufacturing.  Your registration provides access to all 6 conference tracks as well two weeks of on demand access to all of the conference recordings post-event.

The latest science and research on antibody engineering, design and selection diving into critical topics including immuno-oncology, cellular engagers, miniproteins, the Fc region, cancer therapy, novel bi-specifics/multispecifics and much more!

Combining FDA, notified body and industry perspectives to shape the future of medical device regulations

Immuno-Oncology (IO) 360° takes a strategic look at the business and scientific aspects of Immuno-Oncology.  With significant in-put from Lead Advisors Dr. Axel Hoos (former CEO of Scorpion Therapeutics) and Dr. James Gulley (NCI,) the conference examines the current landscape, and reports on the latest advancements in IO to improve and accelerate clinical trials. The audience is comprised of roughly 500 top executives at Pharma companies and Biotechs, as well as the financial community, consultants and leading research organizations in the field of Immuno-Oncology.  

The Next Generation Dx Summit is the nexus for key opinion leaders across the world to share recent progress in diagnostic advancement and technology innovation. The event provides a valuable window on how point-of-care, infectious disease, liquid biopsy and companion diagnostics are changing the standard of care.

The Gene Therapy for Ophthalmic Disorders meeting is bringing you even more world class content, bringing you two tracks of learning to tackle the pressing challenges faced in the pre-clinical stages and in clinical development. This includes challenges faces with drug targets including wet AMD, dry AMD, DME, IRDs and more.

Returning for its seventh year, LSX’s Inv€$tival Showcase directly connects life science and healthcare corporates to global capital and deal-makers. A multi-streamed showcase of early, growth stage and public life science and health technology companies, Investival Showcase provides an unrivalled opportunity to pitch, profile and connect with investors and partners brought together during the biggest week in European life science investment.

PHARMAPACK is the European hub for the pharma packaging and drug delivery device industry. Taking place annually in Paris, the event unites over 5,000 attendees and more than 300 exhibitors for two days of innovation, networking and education.